A founding team with 3 PhDs and 2 serial entrepreneurs.
Co-founder · CEO
€40M+ raised
Serial entrepreneur. Co-founded Sulapac, taking a new biomaterial from laboratory to global brands including Chanel. Also co-founded Ovido, which has built an AI-capable information system. At Velocin she drives strategy and fundraising.
Co-founder · CSO · Adjunct Professor
20+ years in vaccine R&D
Established a world-leading research group in enterovirus protein vaccines. €3M+ competitive non-dilutive funding; leads protein vaccine science and preclinical development.
Co-founder · COO
VLP vaccine co-inventor
Vast knowledge of protein vaccine platform development and partnerships. Has built an extensive vaccine development partner network.
Co-founder · CTO
30 years in technology
Serial entrepreneur who has co-founded several AI-native software startups and built parametric information systems in finance; leads end-to-end in silico development.
Velocin’s protein-based vaccine innovation was born in a world-leading research group of enterovirus virus-like particle vaccines, with over 15 years of research at Tampere University behind it.